Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study shows COVID vaccination highly protective against death, especially for older age groups

Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.

1 Nov 2021

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is one of the most important ways of fighting the ongoing COVID-19 pandemic, the recommendations for vaccination for pregnant and breastfeeding women are not consistent.

1 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Environmental and social factors associated with higher rates of pediatric pneumonia

A new study led by researchers in the Louisiana State University Superfund Research Program demonstrates that children who are exposed to a certain type of environmental air pollution are more likely to contract community acquired pneumonia, or CAP, and to be hospitalized for longer periods of time.

29 Oct 2021

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.

29 Oct 2021

SARS-CoV-2 incidence and mortality in US school opening model

Researchers reported regional variations on the impact of school reopening policy on the community rate of SARS-CoV-2 infection.

29 Oct 2021

Causal effect of school closures on reducing COVID-19 spread in Japan

A new study estimated the causal effect of school closures on reducing the spread of COVID-19.

29 Oct 2021

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.

29 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A new study compares healthcare workers who underwent homologous Ad26.COV2.S booster vaccination to those who underwent heterologous boosting.

28 Oct 2021

A novel approach to improve the stability of Remdesivir

A recent study discusses a novel method to enhance the stability of Remdesivir.

28 Oct 2021

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

A new study examined protection against symptomatic coronavirus disease 2019 (COVID-19) from non-Delta variants using data from randomized control trials.

28 Oct 2021

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

As CCoV-HuPn-2018 has been recently isolated in a child's respiratory swab, researchers from the University Of Washington have been examining the structure of the virus.

28 Oct 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study shows COVID vaccination highly protective against death, especially for older age groups

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

New Canadian serology solution for SARS-CoV-2 infections and vaccination

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

Environmental and social factors associated with higher rates of pediatric pneumonia

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

SARS-CoV-2 incidence and mortality in US school opening model

Causal effect of school closures on reducing COVID-19 spread in Japan

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

How long does natural or vaccine-induced immunity to COVID last?

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A novel approach to improve the stability of Remdesivir

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in